CBSCBS News·2hHealth
score-0.65
Medical Community Calls for Clearer Prescribing Standards as Experimental Weight Loss Drug Retatrutide Awaits FDA Review
Original
Safety concerns over doctors prescribing experimental weight loss drug not approved by FDA
“Uses alarm-laden language ('safety concerns,' 'experimental,' 'not approved') emphasizing risk without context on prevalence, severity, or regulatory oversight mechanisms.”